Heart Test Laboratories (Heart Test Laboratories) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Heart Test Laboratories's net issuance of preferred for the three months ended in Jan. 2024 was $0.00 Mil. The number is 0, which means that Heart Test Laboratories has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Heart Test Laboratories's net issuance of preferred for the trailing twelve months (TTM) ended in Jan. 2024 was $0.00 Mil.

Heart Test Laboratories Net Issuance of Preferred Stock Historical Data

The historical data trend for Heart Test Laboratories's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories Net Issuance of Preferred Stock Chart

Heart Test Laboratories Annual Data

Trend

Apr20

Apr21

Apr22

Apr23

Net Issuance of Preferred Stock

1.18

0.20

Heart Test Laboratories Quarterly Data
	Apr20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial									-	-	-	-	-

Heart Test Laboratories Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Heart Test Laboratories Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Heart Test Laboratories (Heart Test Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

550 Reserve Street, Suite 360, Southlake, TX, USA, 76092

Website

https://www.heartsciences.com

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.

Executives

David R. Wells	director	2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent	director	750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz	director, officer: See Remarks	3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson	officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson	director, officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092